1,3-Dihydroxyacetone dimer
Common Name: |
1,3-Dihydroxyacetone dimer |
IUPAC Name: |
2,5-bis(hydroxymethyl)-1,4-dioxane-2,5-diol |
Molecular Formula: |
C8H8O2 |
SMILES: |
C1C(OCC(O1)(CO)O)(CO)O |
Inchi: |
1S/C6H12O6/c7-1-5(9)3-12-6(10,2-8)4-11-5/h7-10H,1-4H2 |
Inchi Key: |
KEQUNHIAUQQPAC-UHFFFAOYSA-N |
Cas No: |
62147-49-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
136.15 |
Mass (g/mol) |
180.063 |
Molar Refractivity |
37.94 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
6 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
75.00 to 80.00 |
Boiling Point (°C@760.00mm Hg) |
448.00 to 449.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.12 |
LogP |
-2.605 |
iLOGP |
1.87 |
XLOGP3 |
1.49 |
WLOGP |
1.61 |
MLOGP |
1.93 |
ESOL Log S |
-1.93 |
ESOL Solubility (mg/ml) |
1.58 |
ESOL Solubility (mol/l) |
0.012 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.65 |
Ali Solubility (mg/ml) |
3.05 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.44 |
Silicos-IT Solubility (mg/ml) |
0.49 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.07 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.479 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.572 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |